| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |